Loading market dashboard
Climb Bio, Inc.
CLYMHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Climb Bio, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $51.01M | $51.01M - $51.01M | $0.00 | -$1.92 | 5 |
| Dec 2029 | $2.89M | $2.89M - $2.89M | $0.00 | -$1.835 | 5 |
| Dec 2028 | $0.00 | $0.00 - $0.00 | $0.00 | -$1.432 | 0 |
| Dec 2027 | $888.9K | $888.9K - $888.9K | $0.00 | -$1.059 | 11 |
| Dec 2026 | $0.00 | $0.00 - $0.00 | $0.00 | -$0.882 | 0 |
| Dec 2025 | $0.00 | $0.00 - $0.00 | $0.00 | -$0.819 | 0 |
| Dec 2024 | $0.00 | $0.00 - $0.00 | $0.00 | -$1.57 | 0 |